Patents by Inventor David Cantillo

David Cantillo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250215582
    Abstract: The present disclosure relates to an electrochemical reactor capable of processing an organic mixture comprising a suspension of a solid and a liquid, wherein the electrochemical reactor comprises an inner electrode, an outer electrode, wherein the inner electrode and the outer electrode are arranged concentrically forming a first cavity therebetween, a first inlet configured for introducing the liquid into the first cavity of the electrochemical reactor, a second inlet configured for introducing the solid into the first cavity of the electrochemical reactor, wherein the first inlet and the second inlet are arranged such that the liquid and the solid are introduced separately, wherein the inner electrode is configured to be rotatable around its longitudinal axis, wherein the inner electrode comprises one or more mixing elements.
    Type: Application
    Filed: March 21, 2023
    Publication date: July 3, 2025
    Inventors: Oliver KAPPE, Florian SOMMER, David CANTILLO
  • Publication number: 20230242547
    Abstract: The present disclosure relates to a process for preparing a nor-opioid compound wherein an opioid precursor compound is electrochemically N-demethylated. The present disclosure further relates to a process for preparing an opioid antagonist compound, wherein an opioid precursor compound is electrochemically N-demethylated and the thus obtained nor-opioid compound is alkylated again at its secondary amine functional group.
    Type: Application
    Filed: May 10, 2021
    Publication date: August 3, 2023
    Inventors: Gabriel GLOTZ, David CANTILLO NIEVES, Christian Oliver KAPPE
  • Publication number: 20190127389
    Abstract: The present invention relates to processes useful in the preparation of morphine analogs and derivatives, such as naltrexone, naloxone and nalbuphine and intermediates in the synthesis of said morphine analogs and derivatives. In a particular example, the process begins with for example oxymorphone, oxycodone, 14-hydroxycodeinone or 14-hydroxymorphinone, and includes the formation of an oxazolidine-containing intermediate using catalytic oxidation.
    Type: Application
    Filed: April 21, 2017
    Publication date: May 2, 2019
    Applicant: Noramco, Inc.
    Inventors: Christopher Oliver Kappe, Bernhard Gutmann, Ulrich Weigl, Patrick Egli, Douglas Phillip Cox, David Cantillo